Compare INVZ & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INVZ | PLX |
|---|---|---|
| Founded | 2016 | 1993 |
| Country | Israel | United States |
| Employees | 415 | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 144.1M | 159.5M |
| IPO Year | N/A | 1996 |
| Metric | INVZ | PLX |
|---|---|---|
| Price | $0.77 | $2.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $2.68 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 3.3M | 833.1K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.22 |
| Revenue | N/A | ★ $52,744,000.00 |
| Revenue This Year | $29.61 | $36.81 |
| Revenue Next Year | $53.57 | N/A |
| P/E Ratio | ★ N/A | $9.55 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.58 | $1.34 |
| 52 Week High | $2.54 | $3.19 |
| Indicator | INVZ | PLX |
|---|---|---|
| Relative Strength Index (RSI) | 53.92 | 53.79 |
| Support Level | $0.62 | $2.06 |
| Resistance Level | $1.01 | $2.16 |
| Average True Range (ATR) | 0.07 | 0.11 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 31.76 | 82.76 |
Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.